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Available online xxxxBackground: Sedentary behaviour (SB) is potentially an important target to improve cardiovascular health. This
study 1) compared SB between cardiovascular disease (CVD) patients and age-matched controls, 2) identified
characteristics associated with high SB levels, and 3) determined the impact of contemporary cardiac rehabilita-
tion (CR) on SB.
Methods: For objective 1, we recruited 131 CVD patients and 117 controls. All participants were asked about their
general characteristics andmedical history. SBwas assessed by anobjective accelerometer (activPAL3micro). For
objective 2, 2584 CVD patients were asked to fill in a questionnaire about their general characteristics, lifestyle,
medical history and their SB. For objective 3, 131 CVD patients were followed over time and measured, pre-, di-
rectly post- and 2 months post-CR.
Results: Objective 1. CVD patients spent 10.4 h/day (Q25 9.5; Q75 11.2) sedentary which was higher compared to
healthy controls (9.4 h/day [Q25 8.4; Q75 10.29]). Objective 2. CVD patients being male, single or divorced,
employed, physically inactive, reporting high alcohol consumption, living in an urban environment, having co-
morbidities and cardiac anxiety demonstrated a greater odds for large amounts of SB.Objective 3. The CRprogram
significantly reduced sedentary time (−0.4 h/day [95%CI -0.7;−0.1]), which remained lower at 2-months post-
CR (−0.3 h/day [95%CI -0.6; −0.03]).
Conclusions: CVDpatients had greater amounts of objectivelymeasured sedentary time compared tohealthy con-
trols. Sedentarism was associated with personal- and lifestyle characteristics, and comorbidities. Participation in
a contemporary CRprogram slightly reduced sedentary time, but tailored interventions are needed to target SB in
CVD patients.
© 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
A physically inactive lifestyle is increasingly common in theWestern
world [1] and is characterized by low levels ofmoderate-to-vigorous in-
tensity physical activity (MVPA) and high levels of sedentary behaviour, Radboud University Medical
s.
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ernational Journal of Cardiolo(SB; i.e. sitting, lying) [2]. Both low MVPA [3,4] and high SB [5–8] have
been independently associatedwith an increased risk for cardiovascular
morbidity andmortality. According to largemeta-analyses [5–7] includ-
ing >1,000,000 individuals, the detrimental health effects of an inactive
lifestyle are largest for individuals with a combination of lowMVPA and
high SB.
Cardiovascular disease (CVD) patients typically report low MVPA
levels [9], which increases the risk for disease progression andmortality
[10–12]. Exercise training is the cornerstone in cardiac rehabilitation
(CR) [13,14], but CR-induced increase in MVPA is often temporarily
and most patients return to an inactive lifestyle within months [15]. In-
formation about SB in patients with CVD is scarce. A recent study foundnder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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patients at 28 days post-discharge [16]. It is unknown how these SB
characteristics differ from age-matched healthy controls, and which
patient- and disease-characteristics are associated with high SB levels.
Such information is necessary to develop and implement SB inter-
ventions for vulnerable patients with CVD. Moreover, CR-induced SB
changes should be evaluated to determine the magnitude and sustain-
ability of potential improvements in SB.
We aimed to 1) compare SB between patients with CVD and age-
matched controls, 2) identify patient- and disease characteristics associ-
ated with high SB levels, and 3) determine the impact of CR on SB. We
hypothesize that patients with CVD are more sedentary compared to
controls. In addition, subject-, lifestyle- and health-related characteris-
tics relate to high SB levels, and SB will not change after CR. Outcomes
from this study can be used to identify high-risk patients with CVD
and to optimize associated secondary prevention strategies.
2. Methods
2.1. Study population
To compare SB characteristics between patients with CVD and
age-matched controls (objective 1), we recruited 131 patients with
CVD from two different hospitals; Radboud University Medical Center
(Nijmegen, the Netherlands) and Rijnstate Hospital (Arnhem, the
Netherlands). Age-matched controls without a history of CVD or CVD
risk factors (i.e. diabetes mellitus, hypertension and hypercholesterol-
emia) were recruited via social media advertisement and via friends
and family of the patients with CVD (n = 117).
To identify patient- and disease characteristics associated with high
levels of SB (objective 2), patients who participated in CR in the past
3 yearswithin four hospitals in theNetherlands (i.e. RadboudUniversity
Medical Centre, Rijnstate Hospital, Jeroen Bosch Hospital and Isala
clinic) were invited by mail or email to complete a questionnaire
(n=7331). In addition, patientswith CVDwere also recruited via social
media channels of the Dutch Heart Foundation. Patients were included
if they were diagnosed with CVD and were eligible for CR based on
theAmericanHeart Association [17] and European Society of Cardiology
[18] guidelines. In total, 2584 patients with CVD were included. The
study protocol conforms to the ethical guidelines of the 1975 Declara-
tion of Helsinki and the medical ethical committee of the Radboud Uni-
versity Medical Center approved the study (#2017–3315; objective 1
and 3, and #2018–4174; objective 2). All participants provided written
informed consent.
To determine the impact of CR on SB (objective 3), we examined all
patients with CVD from objective 1 immediately after and 2 months
after CR. Patients with CVD participating in a CR program with super-
vised exercise training sessions were eligible for participation. Patients
who discontinued CR after the first session of the program were ex-
cluded from the analysis.
2.2. Objective 1: patients with CVD versus healthy controls
Patients and controlswere asked to fill in a questionnaire about their
general characteristics consisting of age, sex, education level, marital
status and employment status. In patients with CVD, characteristics
such as weight, height, smoking status, alcohol consumption, index di-
agnosis, medical treatment, comorbidities, andmedication usewere re-
trieved from the electronic patient files. In age-matched controls,
characteristics such as weight, height, smoking status, alcohol con-
sumption, comorbidities, and medication use were assessed at the re-
search facility.
SB and PA characteristics (i.e. sedentary, standing and stepping
time, and Metabolic Equivalent of Task [MET] values) were measured
using the activPAL3 micro (PAL Technologies Ltd., Glasgow, UK). The
waterproofed device was attached by trained staff on the midline, one2
third of the way down on the right thigh using a breathable hypoaller-
genic dressing. Participants were asked to wear the monitor 24-h/day
over an 8-day period. Participants were asked to complete a diary
with wake and sleep times. The monitors were initialized and
downloaded using the activPAL software 7.2.38 (PAL Technologies
Ltd., Glasgow, UK). The raw data was analysed by a modified version
of the script of Winkler et al. [19] using the sleep/wake diaries. Seden-
tary timewas defined as any waking behaviour characterized by an en-
ergy expenditure ≤1.5 MET [20] while in a seated, reclined or lying
posture [21,22]. Light intensity physical activity (LIPA) was defined as
standing time combined with stepping time with MET-values <3.
Moderate-to-vigorous physical activity (MVPA) was defined as
stepping time with MET-values ≥3 [23]. The accumulation of sedentary
time was defined as short (<5 consecutive minutes), medium (5–29
consecutive minutes) and prolonged (≥30 consecutive minutes) seden-
tary bouts.
2.3. Objective 2: characteristics associated with high SB levels
Patientswith CVDwhoparticipated in CR in the past 3 yearswere in-
vited to complete a questionnaire. Patients who dropped out of CRwere
included in the analyses. The questionnaire inquired about age, sex,
weight, height, marital status, education level, employment status, in-
come, health, lifestyle factors, CR program characteristics, personality
and living environment. Body mass index (BMI) was calculated as
weight in kilograms divided by height in meters squared. Health-
related information contained self-reported CVD diagnosis, CVD treat-
ment, medication use, comorbidities, pain and limitations of physical
movement in daily life circumstances, and cardiac anxiety [24,25]. Car-
diac anxiety was assessedwith a validated questionnaire and contained
heart-focused anxiety, which is the fear of cardiac-related stimuli and
sensations because of their perceived negative consequences [24]. Life-
style factors were the average number of sleeping hours per night,
smoking status, alcohol consumption and motives for PA (i.e. doctor's
advice, fitness, weight reduction, habit, health, pleasure, social contact
and stress reduction) using a 5-point Likert scale. Heavy alcohol drink-
ing was defined as >14 alcoholic drinks per week for men and > 7 for
women [26]. Personalitywasdeterminedon thebig-five personality do-
mains (i.e. extraverted, agreeable andwarm, conscientious, emotionally
stable, and open to new experiences) using the ten-item personality in-
ventory (TIPI) [27]. Finally, patients were asked about their living envi-
ronment (i.e. urban, transition or rural area) and their satisfaction about
possibilities walking and cycling in the neighbourhood using a 5-point
Likert scale.
Sedentary timewas assessed in nine different settings using the Sed-
entary Behaviour Questionnaire [28,29]. The nine itemswere completed
forweekdays andweekenddays separately, and stratified into three do-
mains; occupation, transportation and leisure time. Leisure time activi-
ties included domestic activities. The average amount of sedentary time
per day was calculated by multiplying weekdays estimates by 5 and
weekend days estimates by 2 and dividing this by 7. Since there are
no evidence-based cut-off values for high levels of sedentary time, we
dichotomized sedentary time based on the median value (8 h/day).
High levels of sedentary time during transportation, occupation and lei-
sure time sitting were based on the 75% percentile (i.e. 1 h/day, 3.5 h/
day, and 8 h/day, respectively). PA volumes were determined for differ-
ent domains (i.e. occupation, transportation, leisure and household)
using the Short QUestionnaire to ASsess Health enhancing physical ac-
tivity (SQUASH) questionnaire [30]. Weekly PA was converted into
METs using the Adult Compendium of Physical Activities [31]. For each
activity, the appropriate MET-score was selected (i.e. walking at
5.6 km/h [or 3.5 mph] = 4.3 METs or cycling at moderate effort = 8.0
METs) and multiplied by the number of minutes per week spent on
the specific activity. The sum of all activities determined the total
METs-minutes per week. These MET-minutes per week values were
classified into four quartiles.
Table 1
Baseline characteristics of patients (n = 131) participating in cardiac rehabilitation com-
pared to healthy age-matched controls (n = 117).
Patient characteristics Patients
N = 131
Controls
N = 117
P-value
Age 63 [56, 69] 60 [54, 67] 0.078
Sex (female) 33 (25%) 44 (38%) 0.049
Body mass index <0.001
Normal 37 (29%) 73 (62%)
Overweight 57 (45%) 36 (31%)
Obesity 33 (26%) 8 (7%)
Marital status (married) 89 (68%) 86 (74%) 0.412
Education level <0.001
Low 24 (18%) 7 (6%)
Middle 63 (48%) 44 (38%)
High 44 (34%) 66 (56%)
Current working status (employed) 38 (29%) 73 (62%) <0.001
Cardiovascular disease
Acute coronary syndrome
STEMI 40 (31%) Na
NSTEMI 28 (22%) Na
Angina Pectoris 27 (21%) Na
Congenital heart disease 2 (2%) Na
Heart failure 5 (4%) Na
Heart rhythm disorder 6 (5%) Na
Heart valve disease 14 (11%) Na
Other cardiovascular diseases 6 (5%) Na
Medication use Na
ACE-inhibitor/Angiotensin
receptor blockers
91 (70%) Na
Antiarrhythmic 14 (11%) Na
Anti-coagulants 26 (20%) Na
Beta-blocker 107 (82%) Na
Calcium-antagonists/nitrates/
dihydropyridines
61 (47%) Na
Cholesterol lowering medication 101 (77%) Na
Diabetes medications and
insulin therapy
18 (14%) Na
Diuretics 22 (17%) Na
Platelet aggregation inhibitors 107 (82%) Na
Treatment Na
CABG 30 (23%) Na
Electro cardioversion/ablation/
mini-maze procedure
1 (1%) Na
Heart valve replacement 17 (13%) Na
Pacemaker or ICD
implementation
9 (7%) Na
PCI 65 (51%) Na
Medication only 2 (2%) Na
Comorbidities
Arthrosis 6 (5%) Na
COPD 5 (4%) Na
Diabetes mellitus 22 (18%) Na
Dyslipidemia 45 (38%) Na
Hypertension 59 (48%) Na
Rheumatoid arthritis 7 (6%) Na
Lifestyle
High alcohol consumption 9 (8%) 9 (10%) 0.932
Smoking status 0.004
No, never smoked 10 (8%) 9 (8%)
No, but in the past 86 (66%) 53 (46%)
Yes, I currently smoke 35 (27%) 54 (47%)
ACE-inhibitor, angiotensin-converting-enzyme inhibitors; CABG, coronary artery bypass
grafting; COPD, chronic obstructive pulmonary disease; ICD, implantable cardioverter-de-
fibrillator; PCI, percutaneous coronary intervention; NSTEMI, non-ST-elevation myocar-
dial infarction; STEMI, ST-elevation myocardial infarction; Na, not applicable.
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Patientswith CVD enrolled inObjective 1were followedover time to
determine the impact of CR on SB characteristics and to assess whether
potential changes were sustainable. The CR program contained a 6-
week exercise program of two exercise sessions of 1 h per week option-
ally combined with 3 additional modules focussing on mental health
and stress relief, social health and cardiovascular risk management. All
patients followed the exercise program, but participation in the addi-
tional modules was based on individual needs and preferences. SB and
PA data were collected at baseline (objective 1), directly after and
2 months after the CR program, resulting in a longitudinal database
with 3 distinct measurement periods; pre-CR, post-CR and 2 months
post-CR.
2.5. Statistical analyses
Baseline characteristics were summarized asmean for normally dis-
tributed continuous variables, as median (Q25 - Q75) for not normally
distributed continuous variables and as number (%) for categorical
variables.
2.5.1. Objective 1
Differences in baseline characteristics between patients with CVD
and age-matched controls were tested using a Student's t-test for nor-
mally distributed continuous variables, a Mann-Whitney U test for not
normally distributed continuous variables, and a Chi-squared test for
categorical variables. Differences in activity patterns (i.e. SB characteris-
tics, MVPA, LIPA, and sleep time) were tested using a Mann-Whitney U
test. To correct for potential confounding factors (i.e. age, sex, BMI, edu-
cation level,employment status, smoking status and season), a multi-
variate linear regression model was used to examine the difference in
sitting time and prolonged sitting bouts between patients with CVD
and age-matched controls.
2.5.2. Objective 2
Univariate associations with age, sex, weight, height, marital status,
education level, employment status, income, health, lifestyle factors,
CR program characteristics, personality and living environment were
determined using logistic regression analysis for total sedentary time
and each domain of sedentary time. Variables with a P-value < 0.10
were included in the multivariate logistic regression model. Backward
selectionwas used to finalize themultivariate logistic regressionmodel.
2.5.3. Objective 3
Changes in activity patterns before and after CR were analysed with
mixed model analyses using random intercepts. Time was described as
categorical variables for pre-CR, post-CR and 2months post-CR. In addi-
tion,multivariatemixedmodel analysis was performed to adjust for po-
tential confounding factors (i.e. age, sex, BMI, education level,
employment status, and disease characteristics).
All statistical tests were 2-sided, and significance was set at P<0.05.
All analyses were performed with R version 3.5.2 using packages ‘lme4’
[32] and ‘lmerTest’ [33].
3. Results
3.1. Patients with CVD versus healthy controls
In total, 131 patients with CVD and 117 individuals without a history
of CVD or CVD risk factors were recruited (Supplemental Fig. 1). Median
age of the patients with CVD was 63 years [Q25 56; Q75 69] and did not
differ from controls (60 years [Q25 54; Q75 67]). Patients were more fre-
quently male (75% vs 62%), had overweight or were obese (71% vs 44%),
had a lower education level (18% vs 6%) and were more often unem-
ployed (71% vs 38%) compared to controls (Table 1). Patients with CVD3
spent 10.4 h/day (Q25 9.5; Q75 11.2) sedentary, performed LIPA for
3.8 h/day (Q25 3.0; Q75 4.7), MVPA for 0.9 h/day (Q25 0.7; Q75 1.1) and
slept for 8.9 h/day (Q25 8.2; Q75 9.6) (Fig. 1 and Supplemental Table 1).
Healthy controls were less sedentary (9.4 h/day), more active (LIPA:
4.9 h/day, MVPA: 1.3 h/day, and slept less (8.3 h/day) compared to pa-
tients with CVD (Fig. 1 and Supplemental Table 1). After adjustment for
potential confounders (i.e. age, sex, BMI, education level, employment
status, smoking status and season), sedentary time remained higher in
Fig. 1. Sleep time (A), sedentary time (B), light intensity physical activity (LIPA) time (C) and moderate-to-vigorous intensity physical activity (MVPA) time (D) in healthy controls and
cardiac patients pre-, post- and 2 months post-cardiac rehabilitation. Data is presented as box plots. Statistically significant differences between healthy controls and patients with
cardiovascular disease (CVD) are presented at the top of each panel, whereas cardiac rehabilitation induced changes among patients with CVD are located on the bottom of each panel.
Patients with CVD spent more time sleeping and sedentary, but less time performing light and moderate-to-vigorous intensity physical activities compared to healthy controls at all
time-points. Cardiac rehabilitation significantly reduced sitting time and increased LIPA, whereas no changes were found for sleeping or MVPA. * p-value <0.05, ** p-value <0.01, *** p-
value <0.001.
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P < 0.001). Interestingly, patients with CVD had fewer short sedentary
bouts (−4.2 bouts/day; 95% CI: −7.8; −0.5, P = 0.02), but more
prolonged sedentary bouts (+1.0 bouts/day; 95% CI: 0.5; 1.61,
P < 0.001) compared to controls (Supplemental Fig. 2). Finally, patients
with CVD were less physically active at light and at a moderate-to-
vigorous intensity compared to controls (LIPA −1.3 h/day [95% CI -1.8;
−0.8] and MVPA−0.4 h/day [95% CI -0.6; −0.3]).3.2. Characteristics associated with high SB levels
2923 Patients with CVD completed our questionnaire. After exclu-
sion for duplicates (n=96), individuals without CVD (n=16), individ-
uals not eligible for CR (n = 67) and invalid questionnaires (n = 160),
2584 patients with CVDwere included for data analyses (Supplemental
Fig. 3). Patients with CVD were 64 (SD 10) years of age and were more
frequently male (72%), overweight or obese (69%), and unemployed
(60%) (Table 2). Sedentary time was most prevalent during leisure
time activities (Supplemental Fig. 4), such as watching TV and movies,
eating and drinking and using the computer. Based on the multivariate
logistic regression model, patients with CVD being male, single or4
divorced, employed, physically inactive, reporting high alcohol con-
sumption, and living in an urban environment demonstrated a greater
odds for high sedentary time (Fig. 2). Weight reduction as motive for
PA was associated with lower sedentary time. Furthermore, the pres-
ence of comorbidities such as type 2 diabetes, hypercholesterolemia
and rheumatoid arthritis and cardiac anxiety also were associated
with high SB levels, but not the type of CVD diagnosis. Correlates for
high levels of domain-specific SB were roughly comparable with total
SB, but some general characteristics, comorbidities and lifestyle factors
differed in magnitude and direction (Supplemental Figs. 5, 6 and 7).3.3. Impact of CR on SB characteristics
Among the 131 patients measured at pre-CR, a total of 17 patients
were lost to follow-up and 8 patients had a measurement failure (i.e.
technical problems with device, early detachment, device lost in mail)
during the post-CR measurements (Supplemental Fig. 1). Patients
with CVD spend significantly less time sedentary following CR
(−0.4 h/day [95% CI -0.7; −0.1], P = 0.005), which remained lower at
2-months post-CR (−0.3 h/day [95% CI -0.6; −0.03], P = 0.03)
(Fig. 1B). Changes in sedentary time were independent of potential
Table 2
Characteristics of cardiovascular disease patients who completed a questionnaire about
general, lifestyle and disease-related characteristics (n = 2584).
Patient characteristics N = 2584
Sex (female) 722 (28%)
Age 64 (10)
Body mass index
Normal 794 (31%)
Overweight 1231 (48%)
Obesity 553 (22%)
Marital status
Unmarried 345 (17%)
Married 1958 (76%)
Widow(er) 125 (5%)
Living together 145 (6%)
Education level
Low 435 (17%)
Middle 1206 (47%)
High 934 (36%)
Current work status
Employed 1025 (40%)
Unemployed (60%)
Health problems 197 (8%)
Retired 1143 (45%)
Other 1535 (8%)
Income
≤1000 euro 78 (3%)
1000–1500 euro 252 (10%)
1500–2500 euro 872 (35%)
≥2500 euro 1265 (51%)
Cardiovascular disease
Acute coronary syndrome 1380 (53%)
Angina pectoris 707 (27%)
Congenital heart defect 25 (1%)
Heart failure 343 (13%)
Heart rhythm disorder 537 (21%)
Heart valve disease 332 (13%)
Other cardiovascular diseases 151 (6%)
Medication use
ACE-inhibitor/Angiotensin receptor blockers 1617 (59%)
Antiarrhythmic 201 (7%)
Anti-coagulants 561 (20%)
Beta-blocker 1670 (61%)
Calcium-antagonists/nitrates/dihydropyridines 710 (26%)
Cholesterol lowering medication 2013 (73%)
Antidiabetic agents and insulin therapy 300 (11%)
Diuretics 618 (23%)
Platelet aggregation inhibitors 1952 (71%)
Treatment
CABG 673 (26%)
Electrical cardioversion/ablation/mini-maze procedure 209 (8%)
Heart valve replacement 331 (13%)
Medication only 312 (12%)
Pacemaker or ICD implantation 255 (10%)
PCI 1499 (58%)
Other cardiothoracic surgery 14 (1%)
Comorbidities
Asthma/bronchitis/COPD 304 (12%)
Arthrosis 315 (12%)
Cancer 239 (9%)
Depression 189 (7%)
Diabetes mellitus
Type 1 28 (1%)
Type 2 326 (13%)
Hypercholesterolemia 896 (35%)
Hypertension 1043 (40%)
Osteoporosis 86 (3%)
Rheumatoid arthritis 99 (4%)
Thyroid disorder 128 (5%)
Transient ischemic attack or stroke 143 (6%)
Lifestyle
Sleeping (hrs/day) 7.4 (1.2)
Smoking status
No, never smoked 784 (30%)
No, but in the past 1617 (63%)
Yes, I currently smoke 173 (7%)
Packyears 21.43 [0.00, 64.29]
High alcohol consumption 253 (10%)
Table 2 (continued)
Patient characteristics N = 2584
Physical activity
Days/week 30 min physically active 5.00 [4.00, 7.00]
MET-minutes per week 3447 [1608, 6165]
MET-minutes per week, leisure 2591 [1200, 4854]
MET-minutes per week, non-leisure 0 [0, 800]
Cardiac rehabilitation
Participation CR
Currently following CR 84 (3%)
Followed CR less than 6 months ago 398 (15%)
Followed CR more than 6 months ago 1784 (70%)
Never followed CR 302 (12%)
Completed CR (no) 113 (5%)
Contribution of CR to recovery 113 (5%)
None 109 (5%)
Little 232 (10%)
Moderate 775 (34%)
High 1142 (51%)
Cardiac anxiety score 18 [12, 25]
ACE-inhibitor, angiotensin-converting-enzyme inhibitors; CABG, coronary artery bypass
grafting; COPD, chronic obstructive pulmonary disease; CR, cardiac rehabilitation; ICD, im-
plantable cardioverter-defibrillator; PCI, percutaneous coronary intervention.
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confounders at baseline. No changes in short sedentary bouts were ob-
served following CR. Although prolonged sedentary bouts decreased
significantly post-CR (−0.4 bouts/day [95% CI -0.7; −0.1]), values nor-
malized to baseline values within 2-monts post-CR (−0.2 bouts/day
[95% CI -0.5; 0.1], P = 0.2) (Supplemental Fig. 2C). LIPA increased sig-
nificantly following CR (0.3 h/day [95% CI 0.1; 0.6], P = 0.005)
and remained higher 2-months post-CR (0.4 h/day [95% CI 0.1; 0.6],
P = 0.002). Finally, MVPA and sleep time did not change following CR
or 2-months post-CR. Stratified analyses for weekdays and weekend
days revealed similar outcomes of changes in sedentary time, prolonged
sedentary bouts, LIPA and MVPA (Supplemental Figs. 8 and 9).
4. Discussion
This study presents novel findings related to the prevalence, corre-
lates and CR-induced changes of sedentary behaviour of patients with
CVD. First, patients with CVD show significantly higher sedentary time
and lower levels of PA compared to healthy, age-matched controls. Es-
pecially the greater accumulation of prolonged, uninterrupted seden-
tary bouts contributed to higher SB time spent by patients with CVD.
Second, general characteristics (i.e. sex, marital status, employment
status), lifestyle characteristics (i.e. physical inactivity, alcohol con-
sumption, living environment, motives for PA) and presence of co-
morbidities (i.e. type 2 diabetes, hypercholesterolemia, rheumatoid
arthritis, and cardiac anxiety), but not the type of CVD diagnosis, were
associated with higher levels of sedentary time among patients with
CVD. Third, patients with CVD demonstrated a small, but significant re-
duction in sedentary time following a 6-weeks CR programwith super-
vised exercise training sessions. Sedentary time wasmostly replaced by
LIPA, whereas no changes in MVPA were observed. Taken together,
these results highlight the high prevalence of SB in patients with CVD,
and provide novel and important information on factors that are related
to SB. These insights are relevant in the development of new strategies
to stimulate patients with CVD to move more and sit less as CR pro-
grams only have small-to-modest effects on SB.
4.1. Patients with CVD versus controls
In linewith our hypothesis, patients with CVD demonstrated a signif-
icantly higher SB and lower PA compared to age-matched controls, mak-
ing them vulnerable to adverse outcomes [5]. In addition to total
Fig. 2. Characteristics associatedwith high levels of sedentary time (≥8 h/day) in 2584 patients with cardiovascular disease. Data is presented as odds ratios with 95% confidence intervals.
Sex, marital status, employment status, comorbidities, physical activity, alcohol consumption, cardiac anxiety, motives for physical activity and living environment were significantly
associated with high levels of sedentary time.
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of sedentary time importantly contributes to the risk for cardiovascular
events and mortality [13,34]. We found that patients with CVD demon-
strated significantly more prolonged uninterrupted sedentary bouts
compared to controls. These prolonged bouts have previously been
linked to acute detrimental effects on vascular function, blood pressure
and lipids [35], which may contribute to disease progression and long-
term outcomes. Given the high prevalence of SB and prolonged un-
interrupted sedentary bouts among patients with CVD, identification
of factors associated with this unhealthy behaviour facilitates early rec-
ognition of individuals at risk.
4.2. Characteristics associated with high SB levels
We found that general characteristics (i.e. sex, marital status, em-
ployment status, living environment) and lifestyle-related characteris-
tics (i.e. physical inactivity, alcohol consumption, motives for physical
activity) were associated with total sedentary time of patients with
CVD. It is interesting to note that these factors largely align with predic-
tors of high SB levels in the general population [36,37], suggesting that
SB may be independent of underlying disease. To support this hypothe-
sis, the type of CVD diagnosiswas not related to total sedentary time. On
the other hand, patientswith CVDwith type 2 diabetes, hypercholester-
olemia, and/or rheumatoid arthritis had higher odds of high SB levels.
These findings suggest that existing comorbidities and cardiac anxiety,
but not type of CVD diagnosis, impact SB levels of patients with CVD.
Insight into correlates of SB is important to identify patients with
CVD with the highest SB levels, whereas it also facilitates development
of interventions specifically targeting SB in patients with CVD. For ex-
ample, modifiable factors as habitual physical activity levels, alcohol6
consumption, motives for physical activity, cardiac anxiety and optimal
therapy for comorbidities should be consideredwhen developing SB in-
terventions. Furthermore, sedentary time was primarily spent during
leisure time (Supplemental Fig. 4), suggesting that leisure time seden-
tary activities should be specifically targeted to achieve the largest re-
ductions in total sedentary time.
4.3. Impact of CR on SB characteristics
CR programs are multidisciplinary, including both supervised ex-
ercise training and lifestyle modification, but SB is hardly addressed.
Hence, it was no surprise that sedentary time was high and reduced
only with 0.4 h/day following CR. A recent meta-analysis of observa-
tional studies showed that an objectively measured sedentary
time ≥ 9.5 h/day was associated with an increased risk of all-cause
mortality [6]. These findings suggest that ±75% of our patients
with CVD (pre-CR sedentary time: 10.4 h/day [Q25 9.5; Q75 11.2])
are at risk for the detrimental health effects of SB, making these indi-
viduals highly vulnerable for recurrent cardiovascular events and
premature death. We also found that the reduction in sedentary
time was mainly replaced by LIPA, whereas no changes in MVPA
were found post-CR. These results are in line with a recent meta-
analysis [38] of randomized clinical trials suggesting no change in
both LIPA and MVPA after CR. Although the changes in LIPA and sed-
entary time were small in our study, replacing sedentary time by
LIPA aligns with the contemporary recommendation to ‘move more
and sit less’ [39]. It is important to emphasise that these behavioural
changes occurred in a CR program focusing on increasing PA levels,
rather than reducing SB. This highlights the potency for interven-
tions specifically targeting SB in CR programs, as replacement of
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reduction of all-cause mortality [40]. Moreover, it is recommended
to frequently break-up prolonged sedentary bouts [13,34,41], but
currently no changes in this SB characteristic were observed follow-
ing CR. In further understanding the role of SR, future should evalu-
ate whether CR-induced changes in other cardiovascular risk factors
(e.g. weight, fitness levels, cholesterol levels, blood pressure, medi-
cation use) are related to changes in SB. In addition, it would be in-
teresting to explore whether tailoring CR to maximize changes in
(long-term) SB could improve CR efficacy to reduce CVD morbidity
and mortality.
Taken together, more attention in CR programs is needed to target
high SB levels and prolonged uninterrupted sedentary bouts of patients
with CVD. In this non-exercising population of patients with CVD, such
lifestyle improvementsmay bemore feasible and sustainable compared
to MVPA interventions.
4.4. Strengths and limitations
The strengths of this study include the assessment of both objective
and subjectively measured SB among two relatively large and indepen-
dent cohorts of patients with CVD. Furthermore, longitudinal measure-
mentswere performed to assess the impact of CR on SB, LIPA andMVPA.
Limitations of our study include the lack of a control group of patients
with CVD not participating in CR and the limited follow-up time post-
CR. Normalization of SB and LIPA may occur across longer time periods,
limiting the generalizability of our findings to patients with chronic
CVD. In addition, assessment of SB for objective 2 was based on self-
reported data, which may result in an underestimation of SB. However,
questionnaires provide domain-specific SB which is not available using
objectively measured SB.
5. Conclusion
Patients with CVD demonstrate significantly higher amounts of SB
compared to healthy controls, which may largely be explained through
a more frequent engagement in prolonged, uninterrupted sedentary
bouts. SBwasmost prevalent during leisure time and characteristics as-
sociated with high levels of SB in patients with CVD largely overlapped
with the general population, except for comorbidities and cardiac anxi-
ety. Furthermore, we found low engagement in MVPA in patients with
CVD, which did not change following a CR programwith supervised ex-
ercise training sessions. Therefore, adding interventions specifically
aimed at reducing SB seems an important and feasible target to improve
health in patients with CVD. Since reductions of SB will be replaced by
LIPA and MVPA, our work enforces the health message to ‘sit less and
move more’ in patients with CVD.
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